Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
9.60
-0.15 (-1.54%)
May 9, 2025, 10:43 AM - Market open

Oruka Therapeutics Statistics

Total Valuation

ORKA has a market cap or net worth of $359.43 million. The enterprise value is -$27.70 million.

Market Cap 359.43M
Enterprise Value -27.70M

Important Dates

The next estimated earnings date is Monday, May 19, 2025, before market open.

Earnings Date May 19, 2025
Ex-Dividend Date n/a

Share Statistics

ORKA has 37.44 million shares outstanding.

Current Share Class 37.44M
Shares Outstanding 37.44M
Shares Change (YoY) n/a
Shares Change (QoQ) +192.14%
Owned by Insiders (%) 2.52%
Owned by Institutions (%) 63.84%
Float 24.53M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.96
P/TBV Ratio 0.96
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 28.89, with a Debt / Equity ratio of 0.00.

Current Ratio 28.89
Quick Ratio 28.80
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -59.48

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -24.87%
Revenue Per Employee n/a
Profits Per Employee -$2.53M
Employee Count 28
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -75.30% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -75.30%
50-Day Moving Average 10.09
200-Day Moving Average 20.82
Relative Strength Index (RSI) 48.95
Average Volume (20 Days) 207,065

Short Selling Information

The latest short interest is 2.36 million, so 6.31% of the outstanding shares have been sold short.

Short Interest 2.36M
Short Previous Month 1.52M
Short % of Shares Out 6.31%
Short % of Float 9.63%
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -95.26M
Pretax Income n/a
Net Income -70.95M
EBITDA -95.23M
EBIT -95.26M
Earnings Per Share (EPS) -$4.23
Full Income Statement

Balance Sheet

The company has $375.65 million in cash and $968,000 in debt, giving a net cash position of $392.75 million or $10.49 per share.

Cash & Cash Equivalents 375.65M
Total Debt 968,000
Net Cash 392.75M
Net Cash Per Share $10.49
Equity (Book Value) 382.22M
Book Value Per Share 10.13
Working Capital 363.83M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.09 million and capital expenditures -$206,182, giving a free cash flow of -$63.30 million.

Operating Cash Flow -63.09M
Capital Expenditures -206,182
Free Cash Flow -63.30M
FCF Per Share -$1.69
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ORKA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -19.44%
FCF Yield -17.34%
Dividend Details

Analyst Forecast

The average price target for ORKA is $39.67, which is 313.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target $39.67
Price Target Difference 313.23%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on September 3, 2024. It was a reverse split with a ratio of 0.083333333:1.

Last Split Date Sep 3, 2024
Split Type Reverse
Split Ratio 0.083333333:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1